Privia Health (PRVA) EBITDA (2020 - 2026)

Privia Health has reported EBITDA for 7 years, with the latest figure at $11.9 million in Q2 2026.

• On a quarterly basis, EBITDA rose 238.29% year-over-year to $11.9 million in Q2 2026; TTM through Jun 2026 was $45.5 million, a 121.38% increase from a year earlier, with the FY2025 full-year figure at $35.0 million, up 93.38% from the prior year.
• EBITDA was $11.9 million for Q2 2026 at Privia Health, up from $7.6 million in the prior quarter.
• The five-year high for EBITDA was $14.6 million in Q3 2025, with the low at -$11.2 million in Q1 2022.
• Average EBITDA over 5 years is $4.2 million, with a median of $5.5 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: EBITDA tumbled 237.22% in 2022, then surged 387.56% in 2025.
• Over 5 years, EBITDA stood at $2.5 million in 2022, then tumbled by 32.49% to $1.7 million in 2023, then soared by 219.11% to $5.5 million in 2024, then soared by 108.86% to $11.4 million in 2025, then grew by 4.21% to $11.9 million in 2026.
• The last three EBITDA figures came in at $11.9 million (Q2 2026), $7.6 million (Q1 2026), and $11.4 million (Q4 2025), per Business Quant data.